We have evaluated an Australian cohort of pediatric/adolescent B-ALL patients and identified a significantly higher HMGN1 expression in P2RY8::CRLF2 ALL patients compared with a control subgroup. Here, HMGN1 is linked to precursor B-cell acute lymphoblastic leukemia.